Eicosanoid determination - Masoodi et al.
From LipidomicsWiki
Contents |
Analytes
- 27 Eicosanoids:
PGD1; PGE1; PGF1α; 6-keto-PGF1α; PGB2; PGD2; PGE2; PGF2α; PGJ2; ∆12-PGJ2; 15-desoxy-∆12,14-PGJ2; PGD3; PGE3; PGF3α; TXB2; TXB3; 8-iso-PGE2; 8-iso-15-keto-PGE2; 8-iso-PGF2α; 8-iso-15-keto-PGF2α; 13,14-dihydro-PGE1; 13,14-dihydro-15-keto-PGE1; 13,14-dihydro-PGF1α; 13,14-dihydro-15-keto-PGF1α; 13,14-dihydro-15-keto-PGE2; 13,14-dihydro-PGF2α; 13,14-dihydro-15-keto-PGF2α;
- 1 Internal Standard (IS):
PGB2-d4
Sample Preparation
- homogenisation of tissue samples (in H2O)
- adjust to 15 % MeOH (final volume: 3 ml)
- addition of 40 ng PGB2-d4 (IS)
- incubation (on ice, 30 min)
- centrifugation (3000 rpm, 5 min)
- acidification (0.1 M HCl; pH = 3.0)
SPE
column | equilibration | wash | elution |
---|---|---|---|
C18-E
(500 mg, 6 ml, Phenomenex) | 20 ml MeOH; 20 ml H2O | 200 μl MeOH (10 %); 20 ml H2O; 10 ml Hexan | 15 ml HCOOMe |
- evaporation of solvents
- addition of 100 μl EtOH (stored at -20 °C)
Material | Material used | Internal Standard(s) | Internal Standard(s) added |
---|---|---|---|
rat brain tissue | |||
rat liver tissue | |||
rat plasma | |||
rat urine |
Instrumentation and Method
Autosampler
- Type: 2690 (Waters)
- Injection volume: 5 μl
- Wash solvent: n.d.
- T (autosampler chamber): 8 °C
HPLC
- Type: Alliance 2695 (Waters)
- Column: Gemini C-18 (2.0 * 150 mm, 5 μl, Phenomenex)
- T column: n.d.
- Solvents:
- A: CH3CN / H2O / CH3COOH (45 / 55 / 0.02)
- B: CH3CN / H2O / CH3COOH (90 / 10 / 0.02)
- Gradient:
Time [min] | Flow [ml/min] | % Solvent A | % Solvent B |
---|---|---|---|
0-8 | 0,2 | 100 | 0 |
8,1-12 | 0,2 | 50 | 50 |
12,1-20 | 0,2 | 30 | 70 |
20,1-30 | 0,2 | 100 | 0 |
- Run time: 30 min (10 min wash cycle included)
Mass Spectrometer
- Type: triple quadrupole Quattro Ultima MS (Waters)
- Ionization mode: ESI negative
- Capillary voltage: 3500 V
- T (source): 120 °C
- T (desolvation): 360 °C
- Cone voltage: 35 V
- MS/MS-conditions:
- Scan modi: Q1, MS2, MRM
- Collision energy: optimized (12 - 38 eV)
- Dwell time: 0.2 s
- MRM table:
Analyte | MRM [m/z] | Collision energy [eV] |
---|---|---|
PGD1 | 353 -> 317 | 15 |
PGE1 | 353 -> 317 | 15 |
PGF1α | 355 -> 311 | 25 |
6-keto-PGF1α | 369 -> 163 | 23 |
PGB2 | 333 -> 175 | 20 |
PGB2-d4 | 337 -> 179 | 20 |
PGD2 | 351 -> 271 | 17 |
PGE2 | 351 -> 271 | 17 |
PGF2α | 353 -> 193 | 25 |
PGJ2 | 333 -> 271 | 15 |
Δ 12-PGJ2 | 333 -> 271 | 15 |
15-deoxy-Δ 12,14-PGJ2 | 315 -> 271 | 15 |
PGD3 | 349 -> 269 | 15 |
PGE3 | 349 -> 269 | 15 |
PGF3α | 351 -> 193 | 25 |
TXB2 | 369 -> 169 | 17 |
TXB3 | 367 -> 169 | 15 |
8-iso-PGE2 | 351 -> 315 | 15 |
8-iso-15-keto-PGE2 | 349 -> 113 | 23 |
8-iso-PGF2α | 353 -> 193 | 25 |
8-iso-15-keto-PGF2α | 351 -> 315 | 15 |
13,14-dihydro-PGE1 | 355 -> 337 | 15 |
13,14-dihydro-15-keto-PGE1 | 353 -> 335 | 12 |
13,14-dihydro-PGF1α | 357 -> 113 | 38 |
13,14-dihydro-15-keto-PGF1α | 355 -> 193 | 32 |
13,14-dihydro-15-keto-PGE2 | 351 -> 333 | 12 |
13,14-dihydro-PGF2α | 355 -> 311 | 30 |
13,14-dihydro-15-keto-PGF2α | 353 -> 113 | 28 |
Data analysis and quantification
Data handling
Isotope correction
Calibration and quantification
Method Validation
Accuracy
Precision
LOD
n.d.
LOQ
n.d.
Recovery
Linearity
n.d.
Reference
Contact
- School of Pharmacy; University of Bradford; Richmond Road; Bradford BD7 1DP; UK.
- e-mail: a.nicolaou@bradford.ac.uk